We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
An FDA inspection at a medical device facility in Akita, Japan revealed nonconformities with process and software validation, as well as complaint handling and device history records. Read More
GMP violations revealed during an FDA inspection include a lack of written procedures for design control, CAPA actions, and complaint handling. Read More
An FDA inspection at a medical device facility in Akita, Japan revealed nonconformities in process and software validation, as well as complaint handling and device history records. Read More
The FDA cited drug manufacturer Immunostics over CAPA procedure issues, inadequate complaint handling, calibration deficiencies and other problems at the firm’s Eatontown, New Jersey facility. Read More
The FDA issued a warning letter to Becton Dickinson for distributing adulterated and misbranded devices, among other significant CGMP violations. Read More
CDRH is looking to enroll a total of nine participants in its new pilot program aimed at identifying best practices for quality product manufacturing. Read More
Facilities in India, Lithuania and Texas drew warnings from the FDA for a variety of noncompliances, including inadequate validations, designs and device history records. Read More
CDRH is looking to enroll a total of nine participants in its new pilot program aimed at identifying best practices for quality product manufacturing. Read More
“We are continuing to aggressively investigate this issue, including whether the use of BD tubes led to inaccurate lead test results,” CDRH’s Donald St. Pierre said. Read More
The firm’s recordkeeping made it unclear if the issues described in customer complaints represented adverse events that should have been reported to the FDA. Read More